The Dallas-based unicorn announced March 26 announcement that the series E funding round brings its valuation to $4.8 billion ...
Colossal Biosciences is aiming to revive extinct species like the woolly mammoth. The startup has raised over $400 million to fund its de-extinction and conservation missions. Its founder and CEO ...
Dallas-based tech startup Island announced Wednesday it had raised $250 million in its latest funding round, bringing the ...
Colossal Biosciences CEO Dissects the $10B Startup’s Effort to Bring Back Extinct Animals: Interview
When it comes to the woolly mammoth, for example, Lamm said Colossal works with a litany of the world’s top elephant conservationists. In Kenya, the startup’s collaboration with Save the ...
Colossal Biosciences announced ... That makes it a “decacorn” (or a “unicorn” multiplied by 10). The Dallas-based genetic engineering startup landed $200 million in Series C financing ...
Colossal Biosciences, a startup trying to bring the prehistoric mammoth back from extinction, said it has achieved a first step: the Woolly Mouse. Using DNA and genomics technologies, scientists ...
The CEO of Colossal, a startup that aims to use genetic editing techniques to bring back extinct species, including the wooly mammoth, assured audiences at SXSW that the company has no plans to ...
The traditional blueprint for building a unicorn startup—a billion-dollar company—has long required armies of talent, years of iteration and millions in venture capital. But a seismic shift is ...
Unicorn refers to a privately held startup that has a valuation of $1 billion or more. The term was coined by Aileen Lee, a famed venture capitalist, to reflect the fact that these startups are ...
Geneticists and bioengineers at Colossal BioSciences have bred woolly mice as part of a project to revive mammoths. The scientists managed to achieve this with the help of gene editing technology ...
The Dallas-based unicorn announced March ... funding round by a Dallas-Fort Worth startup so far in 2025, topping a $200 million mega-round announced by Colossal Biosciences Inc. in January.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results